These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4971073)

  • 1. [Combined therapy of methacolimycin (sodium colistin methanesulfonate) and Wintomylon (nalidixic acid) in bacillary dysentery].
    Tajime H; Hirayama A; Takayama Y; Imagawa Y
    Nihon Densenbyo Gakkai Zasshi; 1968 Mar; 41(12):445-9. PubMed ID: 4971073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results in the combined use of nalidixic acid with other drugs for bacillary dysentery].
    Sugano T; Tashiro F; Matsumoto T
    Nihon Densenbyo Gakkai Zasshi; 1967 Oct; 41(7):256-67. PubMed ID: 4968896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of bacillary dysentery with Wintomylon].
    Ishikawa J
    Nihon Densenbyo Gakkai Zasshi; 1967 Mar; 40(12):460-2. PubMed ID: 4962909
    [No Abstract]   [Full Text] [Related]  

  • 4. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
    Mahmood A
    J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical study of wintomylon in the treatment of shigellosis.
    Yu PC; Chen HS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
    [No Abstract]   [Full Text] [Related]  

  • 6. Nalidixic acid induced pseudotumour cerebri in children.
    Riyaz A; Aboobacker CM; Sreelatha PR
    J Indian Med Assoc; 1998 Oct; 96(10):308, 314. PubMed ID: 10063299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical characteristics of shigellosis in rural Bangladesh.
    Baqui AH; Zaman K; Yunus M; Mitra AK; Hossain KM; Banu H
    J Diarrhoeal Dis Res; 1988 Mar; 6(1):21-8. PubMed ID: 3251937
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Considerations on dysentery caused by Shigella with multiple resistance to antibiotics].
    Brauner E; Cuciureanu G; Hurmuzache T; Turcu T; Grigoriu A; Cercel I
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(3):221-6. PubMed ID: 5344218
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 11. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.
    Miron D; Torem M; Merom R; Colodner R
    Pediatr Infect Dis J; 2004 Apr; 23(4):367-8. PubMed ID: 15071299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for dysentery.
    Br Med J; 1970 Apr; 2(5700):36-7. PubMed ID: 5443981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of bacillary dysentery with dihydroxy-methyl-furatrizine (Panfran-S)].
    Akiba T; Tomizawa I; Shimode T; Minami R
    Nihon Densenbyo Gakkai Zasshi; 1969 Jan; 42(10):288-95. PubMed ID: 4976477
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic sensitivity of endemic Shigella in Mbarara, Uganda.
    Legros D; Ochola D; Lwanga N; Guma G
    East Afr Med J; 1998 Mar; 75(3):160-1. PubMed ID: 9640814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations on tetracycline therapy of acute bacillary dysentery].
    Băliban A; Simu V; Văleanu L
    Microbiol Parazitol Epidemiol (Bucur); 1968; 13(4):325-7. PubMed ID: 5700956
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of our patients with dysentery].
    Iványi J; Pavlovity D
    Ther Ggw; 1966 Jun; 105(6):822-6. PubMed ID: 5333868
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis.
    Nelson JD; Shelton S; Kusmiesz HT; Haltalin KC
    Clin Pharmacol Ther; 1972; 13(6):879-86. PubMed ID: 4673233
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology, clinical aspects and drug therapy of bacterial dysentery].
    Schöne W; Tausche P
    Z Arztl Fortbild (Jena); 1973 Oct; 67(19):967-72. PubMed ID: 4590540
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical observations on 107 cases of acute bacillary dysentery treated with Chaenomeles lagenanid (Loisel) Kaidz].
    Guo CL
    Zhonghua Yi Xue Za Zhi; 1984 Nov; 64(11):689-90. PubMed ID: 6442609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.